Clinical Trial Update: Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing clopidogrel and prasugrel in patients with acute coronary syndrome has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2012-10-26